New Publication on Humanized Mouse Tumor Models
August 30, 2024
GemPharmatech and Simcere Zaiming Pharmaceutical Co, Ltd. have collaborated on a newly published paper titled, "Technical considerations and strategies for generating and optimizing humanized mouse tumor models in immuno-oncology research," published in the academic journal International Immunopharmacology. Read more
GemPharmatech provided the BALB/c-hTNFR2 KI mice and CT26-hTNFR2 KI cell line in this study, as well as conducted the research of hTNFR2-GEMM.
| The hTNFR2-GEMM featured in the article |
Construction, characterization and validation of a hTNFR2-GEMM model
